• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降脂治疗中红曲米导致的勃起功能障碍 1 例

A case of erectile dysfunction induced by red yeast rice in lipid-lowering therapy.

机构信息

Shanghai University of Sport, Shanghai, 200438, China.

Yuxi Normal University, Yuxi, 653100, China.

出版信息

Phytother Res. 2018 May;32(5):953-954. doi: 10.1002/ptr.6025. Epub 2018 Jan 22.

DOI:10.1002/ptr.6025
PMID:29356231
Abstract

This paper studies a 39-year-old male patient who takes red yeast rice (RYR) for self-therapy in lipid-lowering for 3 weeks. Results show that RYR can decrease most of the blood lipid components but without selectivity. During the treatment, the patient developed erectile dysfunction (ED) and accompanied by a dramatic decrease in sexual desire. The ED symptom gradually disappeared within 5 weeks after stopping RYR intake.

摘要

本文研究了一位 39 岁男性患者,他自行服用红曲(RYR)进行降脂治疗,为期 3 周。结果表明,RYR 可以降低大多数血脂成分,但没有选择性。在治疗过程中,该患者出现勃起功能障碍(ED),并伴有性欲明显下降。停止服用 RYR 后,ED 症状在 5 周内逐渐消失。

相似文献

1
A case of erectile dysfunction induced by red yeast rice in lipid-lowering therapy.降脂治疗中红曲米导致的勃起功能障碍 1 例
Phytother Res. 2018 May;32(5):953-954. doi: 10.1002/ptr.6025. Epub 2018 Jan 22.
2
Lipid-lowering drugs and erectile dysfunction.降脂药物与勃起功能障碍
Fam Pract. 2002 Oct;19(5):567. doi: 10.1093/fampra/19.5.567.
3
Do lipid-lowering drugs cause erectile dysfunction? A systematic review.降脂药物会导致勃起功能障碍吗?一项系统评价。
Fam Pract. 2002 Feb;19(1):95-8. doi: 10.1093/fampra/19.1.95.
4
Combined nattokinase with red yeast rice but not nattokinase alone has potent effects on blood lipids in human subjects with hyperlipidemia.纳豆激酶与红曲米联合使用,而非单独使用纳豆激酶,对高脂血症患者的血脂有显著影响。
Asia Pac J Clin Nutr. 2009;18(3):310-7.
5
Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials.红曲米补充剂的安全性:一项随机对照试验的系统评价和荟萃分析。
Pharmacol Res. 2019 May;143:1-16. doi: 10.1016/j.phrs.2019.02.028. Epub 2019 Mar 4.
6
The Impact of Red Yeast Rice Extract Use on the Occurrence of Muscle Symptoms and Liver Dysfunction: An Update from the Adverse Event Reporting Systems and Available Meta-Analyses.红曲米提取物的使用对肌肉症状和肝功能障碍发生的影响:来自不良事件报告系统和现有荟萃分析的更新。
Nutrients. 2024 Feb 2;16(3):444. doi: 10.3390/nu16030444.
7
Rhabdomyolysis linked to Chinese red yeast rice.与中国红曲米相关的横纹肌溶解症。
Prescrire Int. 2008 Apr;17(94):64.
8
Acute liver injury induced by red yeast rice supplement.红曲补充剂引起的急性肝损伤。
BMJ Case Rep. 2019 Mar 25;12(3):e227961. doi: 10.1136/bcr-2018-227961.
9
Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials.含小檗碱(BRB)、多廿烷醇和红曲米(RYR)的营养补充剂组合对高胆固醇血症患者血脂谱的影响:一项随机对照试验的荟萃分析。
Clin Investig Arterioscler. 2016 Jul-Aug;28(4):178-87. doi: 10.1016/j.arteri.2016.03.002. Epub 2016 Apr 28.
10
Phytosterols, red yeast rice, and lifestyle changes instead of statins: a randomized, double-blinded, placebo-controlled trial.植物固醇、红曲米和生活方式改变而非他汀类药物:一项随机、双盲、安慰剂对照试验。
Am Heart J. 2013 Jul;166(1):187-96. doi: 10.1016/j.ahj.2013.03.019. Epub 2013 Apr 30.

引用本文的文献

1
A Comparative Effect of 12-Week Dietary Intervention of Policosanol (Raydel) and Red Yeast Rice (RYR, Kobayashi) in Managing Dyslipidemia and Organ Damage in Hyperlipidemic Zebrafish.12周波立维醇(雷德尔)与红曲米(小林)饮食干预对高脂血症斑马鱼血脂异常及器官损伤的比较效果
Pharmaceuticals (Basel). 2025 Feb 1;18(2):200. doi: 10.3390/ph18020200.
2
Real-World Risk and Outcome of Liver Cirrhosis in Patients with Hyperlipidemia Treated with Red Yeast Rice: A Retrospective Cohort Study.红曲米治疗高脂血症患者肝硬化的真实世界风险与结局:一项回顾性队列研究
J Multidiscip Healthc. 2024 Jul 30;17:3727-3738. doi: 10.2147/JMDH.S466696. eCollection 2024.
3
Nutraceutical Approaches to Dyslipidaemia: The Main Formulative Issues Preventing Efficacy.
营养保健品在血脂异常中的应用:影响疗效的主要制剂问题。
Nutrients. 2022 Nov 11;14(22):4769. doi: 10.3390/nu14224769.
4
Decreased Risk of Stroke in People Using Red Yeast Rice Prescriptions (LipoCol Forte®): a Total Population-Based Retrospective Cohort Study.使用红曲米处方(LipoCol Forte®)的人群中风风险降低:一项基于全人群的回顾性队列研究。
Evid Based Complement Alternat Med. 2022 Apr 23;2022:8160425. doi: 10.1155/2022/8160425. eCollection 2022.
5
Perspectives on Functional Red Mold Rice: Functional Ingredients, Production, and Application.功能性红曲米的研究进展:功能成分、生产与应用
Front Microbiol. 2020 Nov 25;11:606959. doi: 10.3389/fmicb.2020.606959. eCollection 2020.
6
Scientific opinion on the safety of monacolins in red yeast rice.关于红曲米中莫纳可林安全性的科学意见。
EFSA J. 2018 Aug 3;16(8):e05368. doi: 10.2903/j.efsa.2018.5368. eCollection 2018 Aug.
7
Red Yeast Rice: A Systematic Review of the Traditional Uses, Chemistry, Pharmacology, and Quality Control of an Important Chinese Folk Medicine.红曲米:一种重要的中国民间药物传统用途、化学、药理学及质量控制的系统评价
Front Pharmacol. 2019 Dec 2;10:1449. doi: 10.3389/fphar.2019.01449. eCollection 2019.
8
Mini-review: medication safety of red yeast rice products.综述:红曲米产品的用药安全性
Int J Gen Med. 2019 Apr 30;12:167-171. doi: 10.2147/IJGM.S202446. eCollection 2019.
9
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems.含红曲米的膳食补充剂的不良事件:FAERS 和 CAERS 报告系统的比较分析。
Drug Saf. 2018 Aug;41(8):745-752. doi: 10.1007/s40264-018-0661-3.